Patents by Inventor Keith A. Rogers

Keith A. Rogers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030229123
    Abstract: This invention relates to IP receptor antagonists selected from the group of compounds represented by Formula I: 1
    Type: Application
    Filed: April 29, 2003
    Publication date: December 11, 2003
    Inventors: Keith Roger Bley, Robin Douglas Clark, Alam Jahangir, Bruce Andrew Kowalczyk, Francisco Javier Lopez-Tapia, Alexander Victor Muehldorf, Counde O'Yang, Thomas Weitao Sun
  • Patent number: 6596876
    Abstract: This invention relates to IP receptor antagonists selected from the group of compounds represented by Formula I: where: R1 is a group represented by formula (A), (B) or (C);  and other substituents as defined in the specification, and their pharmaceutically acceptable salts or crystal forms thereof; and pharmaceutical compositions containing them; and methods and their use as therapeutic agents.
    Type: Grant
    Filed: May 31, 2002
    Date of Patent: July 22, 2003
    Assignee: Syntex (U.S.A.) LLC
    Inventors: Keith Roger Bley, Robin Douglas Clark, Alam Jahangir, Bruce Andrew Kowalczyk, Francisco Javier Lopez-Tapia, Alexander Victor Muehldorf, Counde O'Yang, Thomas Weitao Sun
  • Publication number: 20030036655
    Abstract: This invention relates to IP receptor antagonists selected from the group of compounds represented by Formula I: 1
    Type: Application
    Filed: May 31, 2002
    Publication date: February 20, 2003
    Inventors: Keith Roger Bley, Robin Douglas Clark, Alam Jahangir, Bruce Andrew Kowalczyk, Francisco Javier Lopez-Tapia, Alexander Victor Muehldorf, Counde O'Yang, Thomas Weitao Sun
  • Patent number: 6472536
    Abstract: This invention relates to IP receptor antagonists selected from the group of compounds represented by Formula I: where: R1 is a group represented by formula (A), (B) or (C); and other substituents as defined in the specification, and their pharmaceutically acceptable salts or crystal forms thereof; and pharmaceutical compositions containing them; and methods for their use as therapeutic agents.
    Type: Grant
    Filed: September 19, 2000
    Date of Patent: October 29, 2002
    Assignee: Syntex (U.S.A.) LLC
    Inventors: Keith Roger Bley, Robin Douglas Clark, Alam Jahangir, Bruce Andrew Kowalczyk, Francisco Javier Lopez-Tapia, Alexander Victor Muehldorf, Counde O'Yang, Thomas Weitao Sun
  • Patent number: 6184242
    Abstract: This invention relates to IP receptor antagonists selected from the group of compounds represented by Formula I: where: R1 is a group represented by formula (A), (B) or (C); and other substituents as defined in the specification, and their pharmaceutically acceptable salts or crystal forms thereof; and pharmaceutical compositions containing them; and methods for their use as therapeutic agents.
    Type: Grant
    Filed: August 20, 1998
    Date of Patent: February 6, 2001
    Assignee: Syntex USA (LLC)
    Inventors: Keith Roger Bley, Robin Douglas Clark, Alam Jahangir, Bruce Andrew Kowalczyk, Francisco Javier Lopez-Tapia, Alexander Victor Muehldorf, Counde O'Yang, Thomas Weitao Sun
  • Patent number: 5910569
    Abstract: Iodothyronine polymers having a plurality of recurring units of formula I ##STR1## in which A is iodo and B, C and D are independently H or iodo are described. Polymers in which A and C are iodo and B and D are independently H or iodo and in which substantially all of the recurring units are L-stereoisomers, have utility in treating thyroid hormone deficiencies.
    Type: Grant
    Filed: August 25, 1997
    Date of Patent: June 8, 1999
    Assignee: Lotus Biochemical Corporation
    Inventors: Keith Roger Latham, Vincent Ernest Latham
  • Patent number: 5767227
    Abstract: Iodothyronine polymers having a plurality of recurring units of formula I ##STR1## in which A is iodo and B, C and D are independently H or iodo are described. Polymers in which A and C are iodo and B and D are independently H or iodo and in which substantially all of the recurring units are L-stereoisomers, have utility in treating thyroid hormone deficiencies.
    Type: Grant
    Filed: November 22, 1994
    Date of Patent: June 16, 1998
    Assignee: Lotus Biochemical Corp.
    Inventors: Keith Roger Latham, Vincent Ernest Latham
  • Patent number: 5692811
    Abstract: A centering apparatus for centering a detachable vehicular wheel with a central opening on a hub. The one-piece centering apparatus fits in an annular groove in the hub pilot boss. The one-piece centering apparatus may be in the shape of a ring, with bendable and resilient fingers extending outwardly from the ring at an angle away from the outer end of the pilot boss. As the wheel is mounted over the hub pilot boss, a flange at the wheel central opening presses against the fingers on the ring. This causes the fingers to bend slightly to compensate for any interference fit. The resilient action of the fingers keeps the wheel centered on the hub. The wheel is then bolted to the wheel assembly. In other embodiments, the centering apparatus has a cross-section in the approximate shape of a "V", "U", "N", or "M", one leg of which serves as the bendable and resilient finger. The fingers may be replaced by a continuous member extending around the circumference of the pilot boss.
    Type: Grant
    Filed: July 30, 1996
    Date of Patent: December 2, 1997
    Assignee: Accuride Corporation
    Inventor: Larry Keith Rogers